Researchers from Cologne, Bochum, Padova and Angers have discovered a novel connection between mitochondrial function, ...

Researchers from Cologne, Bochum, Padova and Angers have discovered a novel connection between mitochondrial function, protein quality control and cellular health, whose failure could be the leading ...

Charcot-Marie-Tooth disease (CMT) refers to a group of genetically heterogeneous neuropathies ... The lack of a clinical practice guideline for the treatment of common problems experienced by children ...

The Charcot-Marie-Tooth Association (CMTA) has announced a $423,000 investment in the Solve-CMT initiative, a groundbreaking ...

A research collaboration has found that besides regulating the fusion of mitochondria, Mitofusin 2 also ensures protein quality control. This discovery could open up new routes to treating ...

A new study reveals that Mitofusin 2 (MFN2) plays a crucial role in protein quality control, preventing harmful protein ...

French biotech Pharnext has seen the value of its shares collapse after it revealed that its lead drug, a treatment for Charcot-Marie-Tooth (CMT) disease, failed to make the grade in a phase 3 trial.

Researchers from Cologne, Bochum, Padova and Angers have discovered a novel connection between mitochondrial function, protein quality control and ...

There are a wide variety of neurological diseases affecting the brain and nervous system. Understanding the specifics can help you navigate diagnostic tests and choose the best course of treatment.

Augustine Therapeutics appoints Gerhard Koenigas Chief Executive Officer as Company Prepares to Enter the ClinicIndustry veteran Gerhard Koenig, ...